TickerFactsScreenerDevelopers

UroGen Pharma Ltd. (URGN) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2015: $301.0K2016: $695.0K2017: $271.0K2018: $560.0K2019: $325.0K2020: $1.22M2021: $752.0K2022: $254.0K2023: $194.0K2024: $295.0K2025: $289.0K$289.0K
2015Capital Expenditures (USD)2025
Fiscal YearCapital ExpendituresChange YoY
2025$289.0K-2.0%
2024$295.0K+52.1%
2023$194.0K-23.6%
2022$254.0K-66.2%
2021$752.0K-38.1%
2020$1.22M+273.8%
2019$325.0K-42.0%
2018$560.0K+106.6%
2017$271.0K-61.0%
2016$695.0K+130.9%
2015$301.0K—